CIM
Confluence Investment Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8M | Buy |
97,226
+700
| +0.7% | +$106K | 0.21% | 99 |
|
|
2025
Q1 | $14.5M | Buy |
96,526
+3,522
| +4% | +$530K | 0.21% | 97 |
|
|
2024
Q4 | $17.2M | Sell |
93,004
-1,955
| -2% | -$361K | 0.24% | 94 |
|
|
2024
Q3 | $18.7M | Sell |
94,959
-313
| -0.3% | -$61.7K | 0.25% | 91 |
|
|
2024
Q2 | $19.7M | Sell |
95,272
-1,685
| -2% | -$348K | 0.28% | 83 |
|
|
2024
Q1 | $26.3M | Sell |
96,957
-257
| -0.3% | -$69.6K | 0.35% | 72 |
|
|
2023
Q4 | $23M | Sell |
97,214
-3,185
| -3% | -$753K | 0.32% | 77 |
|
|
2023
Q3 | $19.7M | Buy |
100,399
+16,398
| +20% | +$3.21M | 0.3% | 81 |
|
|
2023
Q2 | $17.7M | Buy |
+84,001
| New | +$17.7M | 0.26% | 90 |
|
|
2021
Q4 | – | Sell |
-125,409
| Closed | -$51.8M | – | 308 |
|
|
2021
Q3 | $51.8M | Sell |
125,409
-59,972
| -32% | -$24.7M | 0.73% | 54 |
|
|
2021
Q2 | $68.6M | Sell |
185,381
-10,503
| -5% | -$3.89M | 0.91% | 45 |
|
|
2021
Q1 | $56.8M | Sell |
195,884
-229
| -0.1% | -$66.4K | 0.8% | 46 |
|
|
2020
Q4 | $49M | Sell |
196,113
-3,116
| -2% | -$779K | 0.73% | 49 |
|
|
2020
Q3 | $45.1M | Sell |
199,229
-7,616
| -4% | -$1.72M | 0.73% | 47 |
|
|
2020
Q2 | $36.1M | Buy |
206,845
+40,479
| +24% | +$7.06M | 0.6% | 56 |
|
|
2020
Q1 | $21M | Buy |
+166,366
| New | +$21M | 0.4% | 71 |
|